Two unique and complementary businesses, Henry Schein Animal Health and Vets First Choice, have become a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global scale to empower veterinarians to enhance clinical and practice health. This means providing veterinary practices with a more comprehensive set of integrated services and technology solutions, tools to strengthen client relationships and grow their practice, while driving improved workflow and cost-effectiveness through efficient delivery of next-generation solutions.
Following the completion of the merger on February 7, today's announcement marks the launch of Covetrus, which begins regular-way trading on the Nasdaq Stock Market under the symbol CVET this morning.
President and Chief Executive Officer Benjamin Shaw, joined by members of the company's management team, will celebrate the company's first day of trading by visiting the exchange and ringing the opening bell at Nasdaq.
“Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq,” said Mr. Shaw. “We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes.”
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We're bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,000 employees, serving over 100,000 customers around the globe.
Read more here.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2019 Paulick Report.